Evaluation of multimeric siRNA conjugates for efficient protamine-based delivery into breast cancer cells

Archives of Pharmacal Research

Volumn 38, Issue 1, 2015, Pages 129-136

  Yoo, Hyundong ^a   Mok, Hyejung ^a  

^a Konkuk University   (South Korea)

Author keywords

Charge density; Functional peptide; Gene silencing; Multimeric siRNA; Protamine

Indexed keywords

DRUG CARRIER; PROTAMINE; SMALL INTERFERING RNA;

BREAST TUMOR; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; POLYMERIZATION; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; DRUG CARRIERS; GENE EXPRESSION; HUMANS; POLYMERIZATION; PROTAMINES; RNA, SMALL INTERFERING;

EID: 84943589370     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-014-0359-8     Document Type: Article

References (24)

1. Brewer, L.R., M. Corzett, and R. Balhorn. 1999. Protamine-induced condensation and decondensation of the same DNA molecule. Science 286: 120-123.
2. Choi, Y.S., et al. 2010. The systemic delivery of siRNAs by a cell penetrating peptide, low molecular weight protamine. Biomaterials 31: 1429-1443.
3. Decuzzi, P., et al. 2009. Intravascular delivery of particulate systems: does geometry really matter? Pharmaceutical Research 26: 235-243.
4. Fischer, D., et al. 2004. Poly(diallyldimethylammonium chlorides) and their N-methyl-N-vinylacetamide copolymer-based DNA-polyplexes: role of molecular weight and charge density in complex formation, stability, and in vitro activity. International Journal of Pharmaceutics 280: 253-269.
5. Fischer, D., et al. 2003. In vitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials 24: 1121-1131.
6. Heuer, D.M., S. Saha, and L.A. Archer. 2003. Topological effects on the electrophoretic mobility of rigid rodlike DNA in polyacrylamide gels. Biopolymers 70: 471-481.
7. Huang, Y., et al. 2013. Curb challenges of the "Trojan Horse" approach: smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery. Advanced drug delivery reviews 65: 1299-1315.
8. Kim, W.J., and S.W. Kim. 2009. Efficient siRNA delivery with non-viral polymeric vehicles. Pharmaceutical Research 26: 657-666.
9. Kiselev, A., et al. 2013. Characterization of reducible peptide oligomers as carriers for gene delivery. International Journal of Pharmaceutics 441: 736-747.
10. Kumar, P., et al. 2008. T cell-specific siRNA delivery suppresses HIV-1 infection in humanized mice. Cell 134: 577-586.
11. Kundu, A.K., et al. 2012. Stability of lyophilized siRNA nanosome formulations. International Journal of Pharmaceutics 423: 525-534.
12. Lee, S.H., et al. 2012. Small-interfering RNA (siRNA)-based functional micro- and nanostructures for efficient and selective gene silencing. Accounts of Chemical Research 45: 1014-1025.
13. Makris, M., R.E. Hough, and S. Kitchen. 2000. Poor reversal of low molecular weight heparin by protamine. British Journal of Haematology 108: 884-885.
14. Meade, B.R., and S.F. Dowdy. 2007. Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides. Advanced Drug Delivery Reviews 59: 134-140.
15. Mok, H., et al. 2010. Multimeric small interfering ribonucleic acid for highly efficient sequence-specific gene silencing. Nature Materials 9: 272-278.
16. Mok, H., and T.G. Park. 2008. Self-crosslinked and reducible fusogenic peptides for intracellular delivery of siRNA. Biopolymers 89: 881-888.
17. Nguyen, J., and F.C. Szoka. 2012. Nucleic acid delivery: the missing pieces of the puzzle? Accounts of Chemical Research 45: 1153-1162.
18. Pernodet, N., M. Maaloum, and B. Tinland. 1997. Pore size of agarose gels by atomic force microscopy. Electrophoresis 18: 55-58.
19. Reynolds, F., R. Weissleder, and L. Josephson. 2005. Protamine as an efficient membrane-translocating peptide. Bioconjugate Chemistry 16: 1240-1245.
20. Scholz, C., and E. Wagner. 2012. Therapeutic plasmid DNA versus siRNA delivery: common and different tasks for synthetic carriers. Journal of Controlled Release 161: 554-565.
21. Tseng, Y.C., S. Mozumdar, and L. Huang. 2009. Lipid-based systemic delivery of siRNA. Advanced Drug Delivery Reviews 61: 721-731.
22. Won, Y.W., et al. 2011. Poly(oligo-d-arginine) With Internal Disulfide Linkages as a Cytoplasm-sensitive Carrier for siRNA Delivery. Molecular Therapy 19: 372-380.
23. Wyman, T.B., et al. 1997. Design, synthesis, and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers. Biochemistry 36: 3008-3017.
24. Yewale, C., et al. 2013. Proteins: emerging carrier for delivery of cancer therapeutics. Expert Opinion on Drug Delivery 10: 1429-1448.